Acta Med. 2011, 54: 77-79
https://doi.org/10.14712/18059694.2016.23
CASE 2-2011: Cardiac Amyloidosis
References
1. B, Subret SW, Cha K, et al. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 1997;80:1242.
<https://doi.org/10.1016/S0002-9149(97)00653-X>
2. SW, Cha K, Skinner M, et al. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 1997;78:74.
<https://doi.org/10.1136/hrt.78.1.74>
<PubMed>
3. MA, Lacy MQ, Dispenziery A. Amyloidosis. Hematol Oncol Clin North Am 1999;13:1211.
<https://doi.org/10.1016/S0889-8588(05)70122-2>
4. MA, Rajkumar SV. Primary systemic amyloidosis. Curr Treat Options Oncol 2002;3:261.
<https://doi.org/10.1007/s11864-002-0016-1>
5. W, Al-Sergani H, Mourad W, at al. Amyloid heart disease. Tex Heart Inst J 2005;32:178–84.
6. SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997;336:267–76.
<https://doi.org/10.1056/NEJM199701233360407>
7. RA, Spittell PC, Gertz MA, et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101:395–400.
<https://doi.org/10.1016/S0002-9343(96)00229-X>
8. E, Da Prato L, Ciaccheri M, et al. Familial amyloid polyneuropathy with genetic anticipation associated to a gly47glu transthyretin variant in an Italian kindren. Amyloid 2002;9:35.
<https://doi.org/10.3109/13506120209072443>
9. V, Colli Vignarelli M, Anesi E, et al. The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients. Haematologica 1999;84:218–21.
10. P, Westermark P, Cornwell GG 3rd. Senile systemic amyloidosis. Am J Pathol 1984;117:391–9.
11. C, Peters B, Juenemann G, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002;106:2091.
<https://doi.org/10.1161/01.CIR.0000034511.06350.DF>
12. MK, Lachman HJ, Kuriakose B, et al. An unusual cause of progressive heart failure. Lancet 2001;357:1498.
<https://doi.org/10.1016/S0140-6736(00)04648-1>
13. SW, Bilazarian S, LaValley M, et al. Signal-averaged electrocardiography in patient with AL (primary) amyloidosis. Am Heart J 1997;134:994.
14. A, Rallidis L, Hawkins P, at al. Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis. Am J Cardiol 1999;84:1049.
<https://doi.org/10.1016/S0002-9149(99)00497-X>
15. DS, Gray HH. Restrictive cardiomyopathy in systemic amyloidosis. Q J Med 2003;96:380.
<https://doi.org/10.1093/qjmed/hcg065>
